Six-segments right ventricular global longitudinal strain predicts survival in patients with pulmonary hypertension receiving specific vasodilator therapy

Back

ESC Premium Access

Six-segments right ventricular global longitudinal strain predicts survival in patients with pulmonary hypertension receiving specific vasodilator therapy

Session: Progress in the management of pulmonary hypertension

Topic: Chronic pulmonary hypertension

Speaker: Doctor R. Enache (Bucharest, RO)

Event: ESC Congress 2017

Congress Presentation

About the speaker

Doctor Roxana Enache

University of Medicine and Pharmacy Carol Davila, Bucharest (Romania)

0 follower

9 more presentations in this session

Subcutaneous treprostinil for the treatment of non-operable chronic thromboembolic pulmonary hypertension: a randomized, controlled trial (CTREPH)

Speaker: Doctor R. Sadushi-Kolici (Vienna, AT)

A phase 3 study in an enriched population of pulmonary arterial hypertension patients with long term oxygen use demonstrating improved exercise tolerance with use of ambulatory inhaled nitric oxide

Speaker: Doctor H. Farber (Bollington, GB)

Comparative receptor pharmacology, pre-clinical efficacy and pharmacokinetics of a novel, next-generation prostacyclin receptor agonist, ralinepag (APD811), in humans and rats

Speaker: Doctor J. Adams (San Diego, US)

Access

Abstract

Cardiac magnetic resonance characterization of maladaptive right ventricular hypertrophy in chronic pulmonary hypertension.

Speaker: Doctor I. Garcia Lunar (Madrid, ES)

APD811 (ralinepag), a novel non-prostanoid IP receptor agonist, has potent antiproliferative and vasorelaxant properties in human pulmonary artery

Speaker: Doctor J. Patel (London, GB)

Access the full session

Progress in the management of pulmonary hypertension

Speakers: Doctor R. Enache, Doctor R. Sadushi-Kolici, Doctor H. Farber, Doctor J. Adams, Doctor I. Garcia Lunar...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

Six-segments right ventricular global longitudinal strain predicts survival in patients with pulmonary hypertension receiving specific vasodilator therapy

About the speaker

Doctor Roxana Enache

9 more presentations in this session

Subcutaneous treprostinil for the treatment of non-operable chronic thromboembolic pulmonary hypertension: a randomized, controlled trial (CTREPH)

A phase 3 study in an enriched population of pulmonary arterial hypertension patients with long term oxygen use demonstrating improved exercise tolerance with use of ambulatory inhaled nitric oxide

Comparative receptor pharmacology, pre-clinical efficacy and pharmacokinetics of a novel, next-generation prostacyclin receptor agonist, ralinepag (APD811), in humans and rats

Cardiac magnetic resonance characterization of maladaptive right ventricular hypertrophy in chronic pulmonary hypertension.

APD811 (ralinepag), a novel non-prostanoid IP receptor agonist, has potent antiproliferative and vasorelaxant properties in human pulmonary artery

Access the full session

Progress in the management of pulmonary hypertension

About the event

ESC Congress 2017

ESC 365 is supported by